View in EDS

Phase 1b study of anti-NaPi2b antibody-drug conjugate lifastuzumab vedotin (DNIB0600A) in patients with platinum-sensitive recurrent ovarian cancer.

Saved in:
Bibliographic Details
Title: Phase 1b study of anti-NaPi2b antibody-drug conjugate lifastuzumab vedotin (DNIB0600A) in patients with platinum-sensitive recurrent ovarian cancer.
Authors: Moore KN; University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States of America; Sarah Cannon Research Institute, Nashville, TN, United States of America. Electronic address: Kathleen-Moore@ouhsc.edu., Birrer MJ; University of Alabama, Birmingham, AL, United States of America., Marsters J; Genentech, Inc., South San Francisco, CA, United States of America., Wang Y; Genentech, Inc., South San Francisco, CA, United States of America., Choi Y; Genentech, Inc., South San Francisco, CA, United States of America., Royer-Joo S; Genentech, Inc., South San Francisco, CA, United States of America., Lemahieu V; Genentech, Inc., South San Francisco, CA, United States of America., Armstrong K; Genentech, Inc., South San Francisco, CA, United States of America., Cordova J; Genentech, Inc., South San Francisco, CA, United States of America., Samineni D; Genentech, Inc., South San Francisco, CA, United States of America., Schuth E; Genentech, Inc., South San Francisco, CA, United States of America., Vaze A; Genentech, Inc., South San Francisco, CA, United States of America., Maslyar D; Genentech, Inc., South San Francisco, CA, United States of America., Humke EW; Genentech, Inc., South San Francisco, CA, United States of America., Hamilton EP; Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN, United States of America., Liu JF; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, United States of America.
Source: Gynecologic oncology [Gynecol Oncol] 2020 Sep; Vol. 158 (3), pp. 631-639. Date of Electronic Publication: 2020 Jun 11.
Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-6859 (Electronic) Linking ISSN: 00908258 NLM ISO Abbreviation: Gynecol Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 32534811
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Phase 1b study of anti-NaPi2b antibody-drug conjugate lifastuzumab vedotin (DNIB0600A) in patients with platinum-sensitive recurrent ovarian cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Moore+KN%22">Moore KN</searchLink>; University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States of America; Sarah Cannon Research Institute, Nashville, TN, United States of America. Electronic address: Kathleen-Moore@ouhsc.edu.<br /><searchLink fieldCode="AU" term="%22Birrer+MJ%22">Birrer MJ</searchLink>; University of Alabama, Birmingham, AL, United States of America.<br /><searchLink fieldCode="AU" term="%22Marsters+J%22">Marsters J</searchLink>; Genentech, Inc., South San Francisco, CA, United States of America.<br /><searchLink fieldCode="AU" term="%22Wang+Y%22">Wang Y</searchLink>; Genentech, Inc., South San Francisco, CA, United States of America.<br /><searchLink fieldCode="AU" term="%22Choi+Y%22">Choi Y</searchLink>; Genentech, Inc., South San Francisco, CA, United States of America.<br /><searchLink fieldCode="AU" term="%22Royer-Joo+S%22">Royer-Joo S</searchLink>; Genentech, Inc., South San Francisco, CA, United States of America.<br /><searchLink fieldCode="AU" term="%22Lemahieu+V%22">Lemahieu V</searchLink>; Genentech, Inc., South San Francisco, CA, United States of America.<br /><searchLink fieldCode="AU" term="%22Armstrong+K%22">Armstrong K</searchLink>; Genentech, Inc., South San Francisco, CA, United States of America.<br /><searchLink fieldCode="AU" term="%22Cordova+J%22">Cordova J</searchLink>; Genentech, Inc., South San Francisco, CA, United States of America.<br /><searchLink fieldCode="AU" term="%22Samineni+D%22">Samineni D</searchLink>; Genentech, Inc., South San Francisco, CA, United States of America.<br /><searchLink fieldCode="AU" term="%22Schuth+E%22">Schuth E</searchLink>; Genentech, Inc., South San Francisco, CA, United States of America.<br /><searchLink fieldCode="AU" term="%22Vaze+A%22">Vaze A</searchLink>; Genentech, Inc., South San Francisco, CA, United States of America.<br /><searchLink fieldCode="AU" term="%22Maslyar+D%22">Maslyar D</searchLink>; Genentech, Inc., South San Francisco, CA, United States of America.<br /><searchLink fieldCode="AU" term="%22Humke+EW%22">Humke EW</searchLink>; Genentech, Inc., South San Francisco, CA, United States of America.<br /><searchLink fieldCode="AU" term="%22Hamilton+EP%22">Hamilton EP</searchLink>; Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN, United States of America.<br /><searchLink fieldCode="AU" term="%22Liu+JF%22">Liu JF</searchLink>; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, United States of America.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220365304%22">Gynecologic oncology</searchLink> [Gynecol Oncol] 2020 Sep; Vol. 158 (3), pp. 631-639. <i>Date of Electronic Publication: </i>2020 Jun 11.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Academic+Press%22">Academic Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0365304 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1095-6859 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200908258%22">00908258 </searchLink><i>NLM ISO Abbreviation: </i>Gynecol Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32534811
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.ygyno.2020.05.039
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 631
    Titles:
      – TitleFull: Phase 1b study of anti-NaPi2b antibody-drug conjugate lifastuzumab vedotin (DNIB0600A) in patients with platinum-sensitive recurrent ovarian cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Moore KN
      – PersonEntity:
          Name:
            NameFull: Birrer MJ
      – PersonEntity:
          Name:
            NameFull: Marsters J
      – PersonEntity:
          Name:
            NameFull: Wang Y
      – PersonEntity:
          Name:
            NameFull: Choi Y
      – PersonEntity:
          Name:
            NameFull: Royer-Joo S
      – PersonEntity:
          Name:
            NameFull: Lemahieu V
      – PersonEntity:
          Name:
            NameFull: Armstrong K
      – PersonEntity:
          Name:
            NameFull: Cordova J
      – PersonEntity:
          Name:
            NameFull: Samineni D
      – PersonEntity:
          Name:
            NameFull: Schuth E
      – PersonEntity:
          Name:
            NameFull: Vaze A
      – PersonEntity:
          Name:
            NameFull: Maslyar D
      – PersonEntity:
          Name:
            NameFull: Humke EW
      – PersonEntity:
          Name:
            NameFull: Hamilton EP
      – PersonEntity:
          Name:
            NameFull: Liu JF
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: 2020 Sep
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-electronic
              Value: 1095-6859
          Numbering:
            – Type: volume
              Value: 158
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Gynecologic oncology
              Type: main
ResultId 1